CO204 Primary and Secondary Endpoints Used in Recent (2022) Alzheimer’s Disease (AD) Phase III Clinical Trials
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.2339
https://www.valueinhealthjournal.com/article/S1098-3015(23)02439-7/fulltext
Title :
CO204 Primary and Secondary Endpoints Used in Recent (2022) Alzheimer’s Disease (AD) Phase III Clinical Trials
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02439-7&doi=10.1016/j.jval.2023.03.2339
First page :
Section Title :
Open access? :
No
Section Order :
11667